Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery
Clinical trial NCT01147016 · TERMINATED
Trial details
- NCT number
- NCT01147016
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2017-07-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.